Effects of Fear and Humor Appeals in Public Service Announcements (PSAs) on Intentions to Purchase Medications via Social Media
Abstract
:1. Introduction
2. Literature Review
2.1. Online Medication Sales: The Case of Social Media
2.2. Persuasive Appeals: Fear and Humor
2.3. Persuasive Outcomes and Hypotheses
3. Materials and Methods
3.1. Design and Participants
3.2. Independent and Moderator Variables
3.3. Dependent Variables
3.4. Control Variables
3.5. Stimuli and Manipulation Check
3.6. Procedure
3.7. Data Analysis
4. Results
4.1. Descriptive Results
4.2. Direct Effects of Persuasive Appeal
4.3. Moderation Analysis
4.4. Moderated Mediation Analysis
5. Discussion
5.1. Theoretical Implications
5.2. Public Policy and Practical Implications and Recommendations
5.3. Limitations and Future Research
6. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Appendix A. Sample Experimental Stimuli
References
- ReportLinker. Online Pharmacy Market—Global Outlook & Forecast 2020–2025. Market Research Report, ReportLinker (September). Available online: https://www.reportlinker.com/p05968729/Online-Pharmacy-Market-Global-Outlook-Forecast.html?utm_source=GNW#backAction=1 (accessed on 15 April 2020).
- World Health Organization. Substandard and Falsified Medical Products. Available online: https://www.who.int/news-room/fact-sheets/detail/substandard-and-falsified-medical-products (accessed on 28 January 2021).
- Garrett, L. Policy Innovation Memorandum No. 21, Research Report; Council on Foreign Relations: New York, NY, USA, 2012. [Google Scholar]
- World Health Organization. Counterfeit Medical Products. Available online: https://apps.who.int/gb/ebwha/pdf_files/WHA63/A63_23-en.pdf (accessed on 28 January 2021).
- National Association of Boards of Pharmacy. 2019 Rogue RX Activity Report: The Online Sale of Opioids Continues to Put Lives at Risk; Research Report; National Association of Boards of Pharmacy: Mount Prospect, IL, USA, 2019; Available online: https://nabp.pharmacy/wp-content/uploads/2019/11/Rogue-Rx-Activity-Report-2019.pdf (accessed on 28 January 2021).
- Statista. Share of Consumers in the United States Who Believe They Might Purchase Prescriptions and OTC Medication Online if Confined at Home Due to the Coronavirus as of March 2020. Market Research Report, Statista. Available online: https://www.statista.com/statistics/1106468/likelihood-online-medication-purchase-due-to-coronavirus-home-usa/ (accessed on 28 January 2021).
- Liang, B.A.; Mackey, T.K. Prevalence and global health implications of social media in direct-to-consumer drug advertising. J. Med. Internet Res. 2011, 13, e64. [Google Scholar] [CrossRef] [PubMed]
- Forman, R.F.; Block, L.G. The Marketing of Opioid Medications without Prescription over the Internet. J. Public Policy Mark. 2006, 25, 133–146. [Google Scholar] [CrossRef]
- Cockburn, R.; Newton, P.N.; Agyarko, E.K.; Akunyili, D.; White, N.J. The global threat of counterfeit drugs: Why industry and governments must communicate the dangers. PLoS Med. 2005, 2, e100. [Google Scholar] [CrossRef] [PubMed]
- Coney, S. Direct-to-consumer advertising of prescription pharmaceuticals: A consumer perspective from New Zealand. J. Public Policy Mark. 2002, 21, 213–223. [Google Scholar] [CrossRef]
- King, J.; Koppenhafer, L.; Madrigal, R. Look, Puppies! A Visual Content Analysis of Required Risk Statements Embedded in Direct-to-Consumer Pharmaceutical Advertising. J. Public Policy Mark. 2021, 40, 45–61. [Google Scholar] [CrossRef]
- Roth, M.S. Patterns in Direct-to-Consumer Prescription Drug Print Advertising and Their Public Policy Implications. J. Public Policy Mark. 1996, 15, 63–75. [Google Scholar] [CrossRef]
- Mackey, T.K.; Li, J.; Purushothaman, V.; Nali, M.; Shah, N.; Bardlier, C.; Cai, M.; Liang, B. Big data, natural language processing, and deep learning to detect and chatacterize illicit COVID-19 product sales: Infoveillance study on Twitter and Instagram. JMIR Public Health Surveill 2020, 6, e20764. [Google Scholar] [CrossRef]
- Moyle, L.; Childs, A.; Coomber, R.; Barratt, M.J. #Drugsforsale: An exploration of the use of social media and encrypted messaging apps to supply and access drugs. Int. J. Drug Policy 2019, 63, 101–110. [Google Scholar]
- Mackey, T.K.; Liang, B.A.; Strathdee, S.A. Digital social media, youth, and nonmedical use of prescription drugs: The need for reform. J. Med. Internet Res. 2013, 15, e143. [Google Scholar] [CrossRef]
- Mackey, T.K. Opioids and the Internet: Convergence of technology and policy to address the illicit online sales of opioids. Health Serv. Insights 2018, 11, 1178632918800995. [Google Scholar] [CrossRef]
- Li, J.; Xu, Q.; Shah, N.; Mackey, T.K. A machine learning approach for the detection and characterization of illicit drug dealers on Instagram: Model evaluation study. J. Med. Internet Res. 2019, 21, e13803. [Google Scholar] [CrossRef] [Green Version]
- McCulloch, L.; Furlong, S. DM for Details: Selling Drugs in the Age of Social Media, Research Report. Voteface. Available online: https://volteface.me/app/uploads/2020/08/Volteface-_-Social-Media-report-DM-for-Details.pdf (accessed on 28 January 2021).
- Berman, B. Strategies to detect and reduce counterfeiting activity. Bus. Horiz. 2008, 51, 191–199. [Google Scholar] [CrossRef]
- Wilcock, A.E.; Boys, K.A. Reduce product counterfeit: An integrated approach. Bus. Horiz. 2014, 57, 279–288. [Google Scholar] [CrossRef]
- Wilson, J.M.; Grammich, C.A. Protecting brands from counterfeiting risks: Tactics of a total business solution. J. Risk Res. 2021, 24, 1141–1160. [Google Scholar] [CrossRef]
- Goddard, C.S.; Paulins, V.A. Exploring the Efficacy of Consumer Education with Regard to Consumption of Branded and Luxury Counterfeit Mechandise; International Textile and Apparel Association, Inc.: Vancouver, BC, Canada, 2016. [Google Scholar]
- Herstein, R.; Drori, N.; Berger, R.; Barnes, B.R. Anticounterfeiting strategies and their influence on attitudes of different counterfeit consumer types. Psychol. Mark. 2015, 32, 842–859. [Google Scholar] [CrossRef]
- Lynn, J.R. Effects of persuasive appeals in public service advertising. J. Q. 1974, 51, 622–630. [Google Scholar] [CrossRef]
- O’Keefe, D.J. Persuasion: Theory and Research; Sage: Newbury Park, CA, USA, 1990. [Google Scholar]
- Witte, K. Putting the fear back into fear appeals: The extended parallel process model. Commun. Monogr. 1992, 59, 329–349. [Google Scholar] [CrossRef]
- Lazarus, R.S. Cognition and motivation in emotion. Am. Psychol. 1991, 46, 352. [Google Scholar] [CrossRef]
- Nabi, R.L. A cognitive-functional model for the effects of discrete negative emotions on information processing, attitude change, and recall. Commun. Theory 1999, 9, 292–320. [Google Scholar] [CrossRef]
- Skurka, C.; Niederdeppe, J.; Romero-Canyas, R.; Acup, D. Pathways of influence in emotional appeals: Benefits and tradeoffs of using fear or humor to promote change-related intentions and risk perceptions. J. Commun. 2018, 68, 169–193. [Google Scholar] [CrossRef]
- Cacioppolo, N.; Occa, A.; Chunovskaya, E.V. When is it OK to joke? Adding humor to fear-based colonoscopy screening messages may increase compliance. Humor 2020, 33, 581–602. [Google Scholar] [CrossRef]
- Cacioppo, J.T.; Gardner, W.L. Emotion. Annual Rev. Psych. 1999, 50, 191–214. [Google Scholar] [CrossRef] [PubMed]
- Lang, A. Using the limited capacity model of motivated mediated message processing to design effective cancer communication messages. J. Commun. 2006, 56 (Suppl. 1), S57–S80. [Google Scholar] [CrossRef]
- Lee, S.; Lang, A. Discrete emotion and motivation: Relative activation in the appetitive and aversive motivational systems as a function of anger, sadness, fear, and joy during televised information campaigns. Media Psychol. 2009, 12, 148–170. [Google Scholar] [CrossRef]
- Rogers, R.W. A protection motivation theory of fear appeals and attitude changel. J. Psychol. 1975, 91, 93–114. [Google Scholar] [CrossRef]
- Maddux, J.E.; Rogers, R.W. Protection motivation and self-efficacy: A revised theory of fear appeals and attitude change. J. Exp. Soc. Psychol. 1983, 19, 469–479. [Google Scholar] [CrossRef]
- Williams, K.C. Fear appeal theory. Res. Bus. Econ. J. 2012, 5, 1–21. [Google Scholar]
- Nabi, R.L.; Roskos-Ewoldsen, D.; Carpentier, F.D. Subjective knowledge and fear appeal effectiveness: Implications for message design. Health Commun. 2008, 23, 191–201. [Google Scholar] [CrossRef]
- Peters, G.-J.Y.; Ruiter, R.A.C.; Kok, G. Threatening communication: A critical re-analysis and a revised meta-analytic test of fear appeal theory. Health Psychol. Rev. 2013, 7 (Suppl. 1), S8–S31. [Google Scholar] [CrossRef]
- Esrick, J.; Kagan, R.G.; Carnevale, J.T.; Valenti, M.; Rots, G.; Dash, K. Can scare tactics and fear-based messages help deter substance misuse: A systematic review of recent (2005–2017) research. Drugs Educ. Prev. Policy 2019, 26, 209–218. [Google Scholar] [CrossRef]
- Thompson, L.E.; Barnett, J.R.; Pearce, J.R. Scared straight? Fear-appeal anti-smoking campaigns, risk, self-efficacy and addiction. Health Risk Soc. 2009, 11, 181–196. [Google Scholar] [CrossRef]
- Emery, S.L.; Szczypka, G.; Abril, E.P.; Kim, Y.; Vera, V. Are you scared yet? Evaluating fear appeal messages in tweets about the tips campaign. J. Commun. 2014, 64, 278–295. [Google Scholar] [CrossRef]
- Akyüz, A. The Effectiveness of Using Humor Appeal in Advertising: The Key Takeaways. In Proceedings of the 15th EBES Conference-Lisbon, Lisbon, Portugal, 8–10 January 2015; Instituto Universitário de Lisboa: Lisbon, Portugal, 2015. [Google Scholar]
- Sternthal, B.; Craig, C.S. Humor in advertising. J. Mark. 1973, 37, 12–18. [Google Scholar] [CrossRef]
- Conway, M.; Dubé, L. Humor in persuasion on threatening topics: Effectiveness is a function of audience sex role orientation. Personal. Soc. Psychol. Bull. 2002, 28, 683–873. [Google Scholar] [CrossRef]
- Lammers, H.B.; Leibowitz, L.; Seymour, G.E.; Hennessey, J.E. Humor and cognitive responses to advertising stimuli: A trace consolidation approach. J. Bus. Res. 1983, 11, 173–185. [Google Scholar] [CrossRef]
- Voss, K.E. Using humor in conjunction with negative consequence in advertising. J. Curr. Issues Res. Advert. 2009, 31, 25–39. [Google Scholar] [CrossRef]
- Blanc, N.; Brigaud, E. Humor in print health advertisements: Enhanced attention, privileged recognition, and persuasiveness of preventive messages. Health Commun. 2014, 29, 669–677. [Google Scholar] [CrossRef]
- Yoon, H.J. Using humour to increase effectiveness of shameful health issue advertising: Testing the effects of health worry level. Int. J. Advert. 2018, 37, 914–936. [Google Scholar] [CrossRef]
- Lewis, I.M.; Watson, B.; White, K.M.; Tay, R. Promoting public health messages: Should we move beyond fear-evoking appeals in road safety? Qual. Health Res. 2007, 17, 61–74. [Google Scholar] [CrossRef]
- Brooker, G., Jr. A comparison of the persuasive effects of mild humor and mild fear appeals. J. Advert. 1981, 10, 29–40. [Google Scholar] [CrossRef]
- Mukherjee, A.; Dubé, L. Mixing emotions: The use of humor in fear advertising. J. Consum. Behav. 2012, 11, 147–161. [Google Scholar] [CrossRef]
- Capelli, S.; Sabadie, W.; Trendel, O. Using humor or fear appeal: The moderating role of the source’s attractiveness and the source’s communication habits in an electoral campaign. Rech. Appl. Mark. 2012, 27, 21–43. [Google Scholar] [CrossRef]
- Lee, M.J.; Shin, M. Fear versus humor: The impact of sensation seeking on physiological, cognitive, and emotional responses to antialcohol abuse messages. J. Psychol. 2011, 145, 73–92. [Google Scholar] [CrossRef] [PubMed]
- Zhao, X.; Roditis, M.L.; Alexander, T.N. Fear and humor appeals in “The Real Cost” campaign: Evidence of potential effectiveness in message pretesting. Am. J. Prev. Med. 2019, 56, S31–S39. [Google Scholar] [CrossRef] [PubMed]
- Miron, A.M.; Brehm, J.W. Reactance theory—40 years later. Z. Soz. 2006, 37, 9–18. [Google Scholar] [CrossRef]
- Wong, N.C.H.; Harrison, K.J.; Harvell, L.A. Reactance and public health messages: The unintended dangers of anti-tobacco PSAs. Stud. Media Commun. 2015, 3, 72–83. [Google Scholar] [CrossRef]
- Slavin, M.N.; Earleywine, M. Effects of Messaging and Psychological Reactance on Marijuana Craving. Subst. Use Misuse 2019, 54, 2359–2367. [Google Scholar] [CrossRef] [PubMed]
- Kushawah, A.; Sharma, V. A study of impact of type of appeals in public service advertising. Vindhya Bharti 2017, 2, 96–100. [Google Scholar]
- Shen, L. The effectiveness of fear- vs. empathy-arousing anti-smoking PSAs. Health Commun. 2011, 26, 404–415. [Google Scholar] [CrossRef]
- Dillard, J.P.; Kim, J.; Li, S.S. Anti-sugar-sweetened beverage messages elicit reactance: Effects on attitudes and policy preferences. J. Health Commun. 2018, 23, 703–711. [Google Scholar] [CrossRef]
- Lindsey, L.L.M. Anticipated guilt as behavioral motivation: An examination of appeals to help unknown others through bone marrow donation. Hum. Commun. Res. 2005, 31, 453–481. [Google Scholar] [CrossRef]
- Alhabash, S.; Mundel, S.; Hussain, S.A. Social media advertising: Unraveling the mystery box. In Digital Advertising, 3rd ed.; Rodgers, S., Thorson, E., Eds.; Routledge: New York, NY, USA, 2017; pp. 285–299. [Google Scholar]
- Lutz, R.J. Affective and cognitive antecedents of attitude towards the ad: A conceptual framework. In Psychological Processes and Advertising Effects: Theory, Research, and Applications; Alwit, L.F., Mitchell, A., Eds.; Lawrence Erlbaum Associates: Hillsdale, NJ, USA, 1984; pp. 45–65. [Google Scholar]
- MacKenzie, S.B.; Lutz, R.J.; Belch, G.E. The role of attitude toward the ad as a mediator of advertising effectiveness: A test of competing explanations. J. Mark. Res. 1986, 23, 130–143. [Google Scholar] [CrossRef]
- Janis, I.L. Effects of fear arousal on attitude change: Recent developments in theory and experimental research. Adv. Exp. Soc. Psychol. 1967, 3, 166–224. [Google Scholar]
- Berger, J.; Milkman, K.L. What makes online content viral. J. Mark. Res. 2012, 49, 192–205. [Google Scholar] [CrossRef] [Green Version]
- Hagerstrom, A.; Alhabash, S.; Kononova, A. Emotional dimensionality and online ad virality: Investigating the effects of affective valence and content arousingness on processing and effectiveness of viral ads. In American Academy of Advertising Conference Proceedings (Online); American Academy of Advertising: New York, NY, USA, 2014; p. 109. [Google Scholar]
- Meng, J.; Peng, W.; Tan, P.-T.; Liu, W.; Cheng, Y.; Bae, A. Diffusion size and structural virality: The effects of message and network features on spreading health information on Twitter. Comput. Hum. Behav. 2018, 89, 111–120. [Google Scholar] [CrossRef]
- Tsugawa, S.; Ohsaki, H. Negative messages spread rapidly and widely on social media. In Proceedings of the 2015 ACM on Conference on Online Social Networks: COSN ’15, Palo Alto, CA, USA, 2–3 November 2015; Association for Computing Machinery: Lubbock, TX, USA, 2015; pp. 151–160. [Google Scholar]
- Spears, N.; Singh, S.N. Measuring attitude toward the brand and purchase intentions. J. Curr. Issues Res. Advert. 2004, 26, 53–66. [Google Scholar] [CrossRef]
- Mukerjee, R.; Wu, C.F.J. A Modern Theory of Factorial Design; Springer: New York, NY, USA, 2006. [Google Scholar]
- Dillard, J.P.; Shen, L. On the nature of reactance and its role in persuasive health communication. Commun. Monogr. 2005, 72, 144–168. [Google Scholar] [CrossRef]
- Alhabash, S.; McAlister, A.R.; Hagerstrom, A.; Quilliam, E.T.; Rifon, N.J.; Richards, J.I. Between likes and shares: Effects of emotional appeal and virality on the persuasiveness of anticyberullying messages on Facebook. Cyberpsychol. Behav. Soc. Netw. 2013, 16, 175–182. [Google Scholar] [CrossRef]
- Hayes, A.F. Introduction to Mediation, Moderation, and Conditional Process Analysis: A Regression-Based Approach, 2nd ed.; The Guilford Press: New York, NY, USA, 2018. [Google Scholar]
- Alhabash, S.; McAlistern, A.R.; Lou, C.; Hagerstrom, A. From clicks to behaviors: The mediating effect of intentions to like, share, and comment on the relationship between message evaluations and offline behavioral intentions. J. Interact. Advert. 2015, 15, 82–96. [Google Scholar] [CrossRef]
- Glanz, K.; Volpicelli, K.; Jepson, C.; Ming, M.E.; Schuchter, L.M.; Armstrong, K. Effects of tailored risk communications for skin cancer prevention and detection. The PennSCAPE randomized trial. Cancer Epidemiol. Biomark. Prev. 2015, 24, 415–421. [Google Scholar] [CrossRef]
- Elsantil, Y.G.; Abo Hamza, E.G. A review of internal and external factors underlying the purchase of counterfeit products. Acad. Strateg. Manag. J. 2021, 20, 1–13. [Google Scholar]
- Institute of Medicine; Board on Global Health; Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products. Countering the Problem of Falsified and Substandard Drugs; Gostin, L.O., Buckley, G.J., Eds.; National Academies Press: Washington, DC, USA, 2013. [Google Scholar] [CrossRef]
Statistic | Message 1 | Message 2 | Message 3 | |
---|---|---|---|---|
Attitudes toward the PSA: This PSA is… Bad/Good Negative/Positive Unfavorable/Favorable | Eigenvalue | 2.56 | 2.62 | 2.56 |
% of Var. Exp. | 85.28% | 87.22 | 85.54% | |
Factor Loadings | 0.919–0.928 | 0.932–0.935 | 0.923–0.928 | |
Cronbach’s α | 0.914 | 0.927 | 0.915 | |
Mean (SD) | 5.16 (1.59) | 4.92 (1.74) | 5.15 (1.59) | |
Self-Efficacy After seeing this PSA, I am… able to identify attempts for counterfeit medication sales on SM able to distinguish between counterfeit and legitimate medication on SM confident in my ability to identify counterfeit medications on SM | Eigenvalue | 2.43 | 2.45 | 2.39 |
% of Var. Exp. | 80.94% | 81.76% | 79.63% | |
Factor Loadings | 0.892–0.909 | 0.901–0.908 | 0.884–0.899 | |
Cronbach’s α | 0.882 | 0.888 | 0.872 | |
Mean (SD) | 5.21 (1.40) | 5.12 (1.45) | 5.14 (1.40) | |
Response Efficacy __________ would be an effective way to protect me from buying counterfeit medications Simply avoiding to engage with medication sellers on SM By not clicking on a link to buy medications through social media Leaving a shady website selling medications | Eigenvalue | 1.99 | 2.05 | 1.98 |
% of Var. Exp. | 66.20% | 68.31% | 65.86% | |
Factor Loadings | 0.759–0.855 | 0.769–0.855 | 0.726–0.858 | |
Cronbach’s α | 0.739 | 0.762 | 0.731 | |
Mean (SD) | 5.46 (1.15) | 5.43 (1.19) | 5.46 (1.15) | |
Threat to Freedom This PSA… Threatened my freedom to choose Tried to make a decision for me Tried to manipulate me Tried to pressure me | Eigenvalue | 3.33 | 3.29 | 3.29 |
% of Var. Exp. | 83.36% | 82.36% | 82.33% | |
Factor Loadings | 0.907–0.921 | 0.899–0.916 | 0.882–0.914 | |
Cronbach’s α | 0.933 | 0.928 | 0.928 | |
Mean (SD) | 4.55 (1.80) | 4.55 (1.78) | 4.56 (1.79) | |
Anger This PSA makes me feel… Irritated Angry Annoyed Aggravated | Eigenvalue | 3.57 | 3.52 | 3.59 |
% of Var. Exp. | 89.16% | 87.94% | 89.71% | |
Factor Loadings | 0.940–0.947 | 0.932–0.944 | 0.943–0.950 | |
Cronbach’s α | 0.959 | 0.954 | 0.962 | |
Mean (SD) | 4.22 (2.00) | 4.29 (1.95) | 4.23 (1.98) | |
Viral Behavioral Intentions This PSA is worth sharing with others I will recommend this PSA to others I will “like” this PSA on SM I will “share” this PSA on SM I will “comment” on this PSA on SM | Eigenvalue | 3.97 | 3.97 | 3.96 |
% of Var. Exp. | 79.47% | 79.30% | 79.28% | |
Factor Loadings | 0.869–0.907 | 0.861–0.906 | 0.879–0.908 | |
Cronbach’s α | 0.935 | 0.934 | 0.934 | |
Mean (SD) | 4.94 (1.65) | 4.92 (1.64) | 5.00 (1.61) | |
Behavioral Intentions How likely are you to buy medications through SM referral/link? Not likely at all…Very likely Not probably…Very Probable Not certainly…Certainly Definitely not…Definitely | Eigenvalue | 3.60 | 3.60 | 3.58 |
% of Var. Exp. | 90.05% | 90.09% | 89.45% | |
Factor Loadings | 0.941–0.958 | 0.942–0.957 | 0.936–0.955 | |
Cronbach’s α | 0.963 | 0.963 | 0.961 | |
Mean (SD) | 4.44 (2.07) | 4.41 (2.06) | 4.46 (2.07) |
Predictor | T2F | Anger | APSA | VBI | PI |
---|---|---|---|---|---|
β (SE) [CILL−UL] | β (SE) [CILL−UL] | β (SE) [CILL−UL] | β (SE) [CILL−UL] | β (SE) [CILL−UL] | |
constant | 4.33 (0.62) *** [3.11, 5.54] | 4.58 (0.70) *** [3.22, 5.95] | 3.91 (0.56) *** [2.82, 5.00] | 3.46 (0.60) *** [2.29, 4.63] | 5.50 (0.72) *** [4.08, 6.93] |
Persuasive Appeal (PA) | 1.54 (0.60) * [0.36, 2.71] | 0.90 (0.67) [−0.42, 2.23] | −0.87 (0.54) [−1.93, 0.19] | 0.59 (0.58) [−0.54, 1.73] | 0.50 (0.70) [−0.88, 1.88] |
Risk Perception (RP) | 0.06 (0.07) [−0.08, 0.20] | −0.07 (0.08) [−0.22, 0.09] | 0.15 (0.06) * [0.02, 0.27] | 0.23 (0.07) *** [0.10, 0.36] | −0.26 (0.08) *** [−0.42, −0.11] |
PA x RP | −0.35 (0.10) *** [−0.55, −0.15] | −0.23 (0.12) † [−0.45, 0.002] | 0.23 (0.09) * [0.05, 0.42] | −0.17 (0.10) † [−0.36, 0.03] | −0.14 (0.12) [−0.37, 0.10] |
Gender | −0.23 (0.10)* [−0.43, −0.03] | −0.23 (0.11) * [−0.46, −0.01] | −0.27 (0.09) ** [−0.44, −0.09] | 0.40 (0.10) *** [−0.59, −0.21] | −0.30 (0.12) * [−0.53, −.007] |
Age | 0.004 (0.005) [−0.01, 0.01] | 0.01 (0.01) [−0.002, 0.02] | −0.001 (0.004) [−0.01, 0.01] | 0.01 (0.005) [−0.004, 0.01] | 0.002 (0.006) [−0.01, 0.01] |
Prescription medication | −0.98 (0.12) *** [−1.22, −0.75] | −0.99 (0.13)*** [−1.25, −0.73] | −0.42 (0.11) *** [−0.63, −0.21] | −0.34 (0.12) ** [−0.57, −0.11] | 0.99 (0.14) *** [−1.26, −.71) |
Health insurance | −0.12 (0.13) [−0.37, 0.12] | −0.22 (0.14) [−0.49, 0.06] | 0.23 (0.11) * [−0.45, −0.004] | −0.20 (0.12) [−0.43, 0.04] | −0.16 (0.15) [−0.45, 0.12] |
Education | 0.47 (0.06) *** [0.36, 0.59] | 0.52 (0.07) *** [0.39, 0.64] | 0.35 (0.05) *** [−0.25, 0.45] | 0.40 (0.06) *** [0.30, 0.51] | 0.66 (0.07) *** [0.53, 0.80] |
HH income | −0.26 (0.07) *** [−0.40, −0.12] | −0.32 (0.08) *** [−0.48, −0.15] | −0.14 (0.07) * [−0.27, −0.01] | −0.24 (0.07) *** [−0.38, −0.10] | −0.34 (0.09) *** [−0.51, −0.18] |
Model Statistics | R = 0.49, R2 = 0.24, F(9, 721) = 25.68 *** | R = 0.47, R2 = 0.22, F(9, 721) = 22.17 *** | R = 0.39, R2 = 0.15, F(9, 721) = 14.63 *** | R = 0.39, R2 = 0.15, F(9, 721) = 14.63 *** | R = 0.50, R2 = 25, F(9, 721) = 26.94 *** |
Predictor | T2F β (SE) [CILL-UL] | Anger β (SE) [CILL-UL] | APSA β (SE) [CILL-UL] | VBI β (SE) [CILL-UL] | PI β (SE) [CILL-UL] |
---|---|---|---|---|---|
constant | 4.33 (0.62) *** [3.11, 5.54] | 0.16 (0.78) [−1.38, 1.70] | 2.07 (1.00) * [0.11, 4.04] | 1.64 (1.00) [−0.32, 3.59] | 0.78 (0.84) [−0.86, 2.42] |
PA | 1.54 (0.60) * [0.36, 2.71] | −0.49 (0.40) [−1.27, 0.29] | −1.36 (0.51) ** [−2.36, −0.36] | 0.81 (0.45) † [−0.07, 1.70] | −0.13 (0.37) [−0.87, 0.60] |
RP | 0.06 (0.07) [−0.08, 0.20] | −0.05 (0.11) [−0.27, 0.17] | 0.20 (0.14) [−0.08, 0.30] | −0.10 (0.15) [−0.39, 0.20] | −0.43 *** (0.13) [−0.68, −0.18] |
PA x RP | −0.35 (0.10) *** [−0.55, −0.15] | 0.09 (0.07) [−0.04, 0.23] | 0.34 (0.09) *** [0.17, 0.52] | −0.22 (0.08) ** [−0.38, −0.07] | 0.03 (0.07) [−0.10, 0.16] |
T2F | -- | 1.03 (0.16) *** [0.71, 1.34] | 0.71 (0.34) * [0.04, 1.38] | 0.83 (0.32) ** [0.21, 1.45] | −0.41 (0.26) [−0.92, 0.10] |
Anger | -- | -- | −0.30 (0.30) [−0.90, 0.30] | −0.38 (0.27) [−0.90, 0.14] | 0.07 (0.22) [−0.35, 0.50] |
APSA | -- | -- | -- | −0.01 (0.19) [−0.38, 0.37] | 0.17 (0.18) [−0.18, 0.51] |
VBI | -- | -- | -- | -- | 1.26 (0.19) *** [0.88, 1.63] |
T2F x RP | -- | −0.02 (0.02) [−0.07, 0.03] | −0.06 (0.05) [−0.16, 0.05] | −0.10 (0.05) * [−0.20, −0.01] | 0.13 *** (0.04) [0.05, 0.22] |
Anger x RP | -- | -- | 0.04 (0.05) [−0.05, 0.14] | 0.08 (0.04) * [0.001, 0.17] | 0.03 (0.03) [−0.04, 0.10] |
APSA x RP | -- | -- | -- | 0.08 (0.03) ** [0.02, 0.14] | 0.02 (0.02) [−0.04, 0.07] |
VBI x RP | -- | -- | -- | -- | −0.15 *** (0.03) [−0.21, −0.10] |
Gender | −0.23 (0.10)* [−0.43, −0.03] | −0.02 (0.07) [−0.15, 0.11] | −0.19 (0.09)* [−0.36, −0.02] | −0.18 (0.07) * [−0.33, −0.04] | 0.02 (0.06) [−0.10, 0.14] |
Age | 0.004 (0.005) [−0.01, 0.01] | 0.005 (0.003) [−0.001, 0.01] | −0.003 (0.004) [−0.01, 0.01] | 0.003 (0.004) [−0.005, 0.01] | −0.003 (0.003) [−0.01, 0.002] |
Prescription med. | −0.98 (0.12) *** [−1.22, −0.75] | −0.09 (0.08) [−0.25, 0.07] | −0.11 (0.11) [−0.31, 0.10] | 0.20 (0.09) * [0.02, 0.38] | −0.09 (0.07) [−0.24, 0.05] |
Health insurance | −0.12 (0.13) [−0.37, 0.12] | −0.10 (0.08) [−0.26, 0.07] | −0.18 (0.11) † [−0.39, 0.03] | −0.02 (0.09) [−0.21, 0.16] | 0.03 (0.08) [−0.12, 0.18] |
Education | 0.47 (0.06) *** [0.36, 0.59] | 0.08 *(0.04) * [0.004, 0.16] | 0.20 (0.05) *** [0.10, 0.30] | 0.07 (0.05) [−0.02, 0.15] | 0.11 (0.04) [0.04, 0.18] |
HH income | −0.26 (0.07) *** [−0.40, −0.12] | −0.08 (0.05) [−0.17, 0.02] | −0.06 (0.06) [−0.18, 0.06] | −0.08 (0.05) [−0.19, 0.03] | −0.03 (0.04) [−0.12, 0.06] |
Model Statistics | R = 0.49, R2 = 0.24, F(9, 721) = 25.68 *** | R = 0.85, R2 = 0.73, F(11, 719) = 178.48 *** | R = 0.51, R2 = 0.26, F(13, 717) = 19.46 *** | R = 0.71, R2 = 0.51, F(15, 715) = 50.53 *** | R = 0.90, R2 = 0.81, F(17, 713) = 177.96 *** |
Indirect Effects a | Risk Perception (Moderator) Values | ||||
Lower RP (4.67) | Moderate RP (6.00) | Higher RP (7.00) | |||
β (Boot SE) [Boot CILL-UL] | β (Boot SE) [Boot CILL-UL] | β (Boot SE) [Boot CILL-UL] | |||
PA → T2F → PI | −0.02 (0.03) [−0.09, 0.04] | −0.22 (0.06) [−0.35, −0.11] | −0.48 (0.13) [−0.74, −0.25] | ||
PA → Anger → PI | −0.01 (0.02) [−0.06, 0.02] | 0.01 (0.02) [−0.03, 0.06] | 0.04 (0.04) [−0.03, 0.13] | ||
PA → APSA → PI | 0.06 (0.03) [0.003, 0.14] | 0.18 (0.04) [0.11, 0.26] | 0.28 (0.08) [0.14, 0.44] | ||
PA → VBI → PI | −0.13 (0.06) [−0.25, −0.02] | −0.18 (0.04) [−0.28, −0.11] | −0.15 (0.05) [−0.26, −0.05] | ||
PA → T2F → Anger → PI | −0.02 (0.03) [−0.07, 0.03] | −0.13 (0.04) [−0.21, −0.06] | −0.23 (0.09) [−0.43, −0.09] | ||
PA → T2F → APSA → PI | −0.01 (0.02) [−0.05, 0.02] | −0.05 (0.−02) [−0.09, −0.02] | −0.07 (0.03) [−0.15, −0.02] | ||
PA → T2F → VBI → PI | −0.02 (0.03) [−0.09, 0.03] | −0.04 (0.09, −0.001] | −0.02 (0.02) [−0.06, 0.02] | ||
PA → Anger → APSA → PI | 0.002 (0.004) [−0.004, 0.01] | −0.001 (0.002) [−0.005, 0.003] | 0.0002 (0.005) [−0.01, 0.01] | ||
PA → Anger → VBI → PI | −0.001 (0.006) [−0.02, 0.01] | 0.002 (0.004) [−0.01, 0.01] | 0.006 (0.007) [−0.01, 0.02] | ||
PA → T2F → Anger → APSA → PI | 0.002 (0.005) [−0.01, 0.01] | 0.01 (0.01) [−0.01, 0.02] | −0.001 (0.02) [−0.05, 0.04] | ||
PA → T2F → Anger → VBI → PI | −0.001 (0.001) [−0.02, 0.02] | −0.02 (0.01) [0.05, −0.001] | −0.03 (0.02) [−0.08, −0.004] | ||
PA → T2F → APSA → VBI → PI | −0.01 (0.01) [−0.03, 0.01] | −0.03 (0.01) [−0.06, −0.01] | −0.03 (0.02) [−0.06, −0.01] | ||
PA → Anger → APSA → VBI → PI | 0.001 (0.003) [−0.003, 0.001] | −0.0003 (0.001) [−0.003, 0.002] | 0.0001 (0.002) [−0.003, 0.01] | ||
PA → T2F → Anger → APSA → VBI → PI | 0.002 (0.004) [−0.004, 0.01] | 0.003 (0.01) [−0.01, 0.01] | −0.001 (0.01) [−0.02, 0.02] |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Alhabash, S.; Dong, Y.; Moureaud, C.; Muraro, I.S.; Hertig, J.B. Effects of Fear and Humor Appeals in Public Service Announcements (PSAs) on Intentions to Purchase Medications via Social Media. Int. J. Environ. Res. Public Health 2022, 19, 12340. https://doi.org/10.3390/ijerph191912340
Alhabash S, Dong Y, Moureaud C, Muraro IS, Hertig JB. Effects of Fear and Humor Appeals in Public Service Announcements (PSAs) on Intentions to Purchase Medications via Social Media. International Journal of Environmental Research and Public Health. 2022; 19(19):12340. https://doi.org/10.3390/ijerph191912340
Chicago/Turabian StyleAlhabash, Saleem, Yao Dong, Charlotte Moureaud, Iago S. Muraro, and John B. Hertig. 2022. "Effects of Fear and Humor Appeals in Public Service Announcements (PSAs) on Intentions to Purchase Medications via Social Media" International Journal of Environmental Research and Public Health 19, no. 19: 12340. https://doi.org/10.3390/ijerph191912340
APA StyleAlhabash, S., Dong, Y., Moureaud, C., Muraro, I. S., & Hertig, J. B. (2022). Effects of Fear and Humor Appeals in Public Service Announcements (PSAs) on Intentions to Purchase Medications via Social Media. International Journal of Environmental Research and Public Health, 19(19), 12340. https://doi.org/10.3390/ijerph191912340